Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

850 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm.
Poizeau F, Leducq S, Fardet L, Beylot-Barry M, Chaby G, Chastagner M, Corgibet F, Gouillon L, Jouan N, Jullien D, Acher A, Amatore F, Amici JM, Aubert H, Aubin F, Beneton N, Bouilly D, Bursztejn AC, Buzenet C, Chamaillard-Pujol M, Charles J, Cottencin-Charriere AC, Duval Modeste B, Fauconneau A, Fougerousse AC, Girard C, Goujon C, Khemis A, Le Ru Y, Lepelley-Dupont C, Mahé E, Marcellin X, Nicolas C, Pallure V, Parier J, Quiles N, Stoebner PE, Tauber M, Vermersch A, Viguier M, Villani AP, Chosidow O, Guillot B; Psoriasis Research Group (GRPso) and the Centre of Evidence of the French Society of Dermatology. Poizeau F, et al. Among authors: girard c. Ann Dermatol Venereol. 2024 Sep;151(3):103287. doi: 10.1016/j.annder.2024.103287. Epub 2024 Jul 15. Ann Dermatol Venereol. 2024. PMID: 39013256 Free article.
Effectiveness of biologic therapies in children with palmoplantar plaque psoriasis: An analysis of real-life data from the BiPe cohorts.
Hanafi B, Beauchet A, Di Lernia V, Lasek A, Severino-Freire M, Barbarot S, Hadj-Rabia S, Phan A, Bursztejn AC, Maruani A, Chaby G, Quiles-Tsimaratos N, Phan C, Zitouni J, Mazereeuw-Hautier J, Mahé E; Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie (SFD), Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), and Società Italiana di Dermatologia Pediatrica (S.I.Der.P.). Hanafi B, et al. Pediatr Dermatol. 2023 Sep-Oct;40(5):835-840. doi: 10.1111/pde.15393. Epub 2023 Jul 13. Pediatr Dermatol. 2023. PMID: 37442765
Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort - A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses.
Becherel PA, Reguiai Z, Fougerousse AC, Perrot JL, Begon E, Thomas-Beaulieu D, Mery-Bossard L, Pourchot D, Boulard C, Fite C, Beaziz J, Zaraa I, Lons-Danic D, Badaoui A, Parier J, Chaby G, Estève E, Liegeon AL, Patchinsky A, Muller P, Lepelley-Dupont C, Poreaux C, Jacobzone-Lévêque C, Chassain K, Mohty R, Perrussel M, Garcia C, Girard C, Dillies AS, Amy de la Breteque M, Quiles-Tsimaratos N, Denis D, Maccari F. Becherel PA, et al. Among authors: girard c. Dermatology. 2024;240(5-6):702-712. doi: 10.1159/000540250. Epub 2024 Jul 17. Dermatology. 2024. PMID: 39019015
Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus.
Chasset F, Jaume L, Mathian A, Abisror N, Dutheil A, Barbaud A, Kottler D, Girard C, Jousse-Joulin S, Tauber M, Livideanu CB, Avettand-Fenoel V, Lhote R, Pha M, Amoura Z; EMSED (Etude des maladies systémiques en dermatologie) study group. Chasset F, et al. Among authors: girard c. J Am Acad Dermatol. 2023 Jul;89(1):171-173. doi: 10.1016/j.jaad.2023.02.044. Epub 2023 Mar 5. J Am Acad Dermatol. 2023. PMID: 36878316 No abstract available.
Oesophageal lichen planus: Clinical, endoscopic and fibroscopic characteristics.
Kayal A, Tessier MH, Fricain JC, Vigarios E, Seta V, Isnard C, Husson C, Le Roux-Villet C, Du-Thanh A, Girard C, Velut G, Samimi M, Kayal M, Le Moigne M; GEMUB Group and the French Society of Dermatology. Kayal A, et al. Among authors: girard c. J Eur Acad Dermatol Venereol. 2024 Sep 26. doi: 10.1111/jdv.20342. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39324851 No abstract available.
Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.
Fabre M, Lamoureux A, Meunier L, Samaran Q, Lesage C, Girard C, Du Thanh A, Moulis L, Dereure O. Fabre M, et al. Among authors: girard c. Melanoma Res. 2024 Jun 1;34(3):241-247. doi: 10.1097/CMR.0000000000000963. Epub 2024 Mar 28. Melanoma Res. 2024. PMID: 38546723
850 results